|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2004-2-17
|
|
pubmed:abstractText |
Iodobenzamides are reported to possess an affinity for melanoma. A first selected compound, BZA, was studied in a phase 2 clinical trial on 159 patients as an imaging agent for the detection of primary melanoma and metastases with good results. We report the results of a second phase 2 clinical trial on 40 patients with a new radiopharmaceutical BZA2 (an orthoiodinated BZA analog), which was expected to provide quality images sooner after injection and with better imaging contrast.
|
|
pubmed:language |
fre
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0181-5512
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
27
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
34-9
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:14968075-Benzamides,
pubmed-meshheading:14968075-Choroid Neoplasms,
pubmed-meshheading:14968075-Ciliary Body,
pubmed-meshheading:14968075-Conjunctival Neoplasms,
pubmed-meshheading:14968075-Diagnosis, Differential,
pubmed-meshheading:14968075-Eye Neoplasms,
pubmed-meshheading:14968075-Female,
pubmed-meshheading:14968075-Humans,
pubmed-meshheading:14968075-Iodine Radioisotopes,
pubmed-meshheading:14968075-Liver Neoplasms,
pubmed-meshheading:14968075-Male,
pubmed-meshheading:14968075-Melanoma,
pubmed-meshheading:14968075-Ophthalmoscopy,
pubmed-meshheading:14968075-Predictive Value of Tests,
pubmed-meshheading:14968075-Radiopharmaceuticals,
pubmed-meshheading:14968075-Sensitivity and Specificity,
pubmed-meshheading:14968075-Skin Neoplasms,
pubmed-meshheading:14968075-Tomography, X-Ray Computed,
pubmed-meshheading:14968075-Uveal Neoplasms
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
[Phase 2 clinical study of 123I-N-(2-diethylaminoethyl)-2-iodobenzamide in the diagnostic of primary and metastatic ocular melanoma].
|
|
pubmed:affiliation |
Service d'Ophtalmologie, CHU, Hôpital Gabriel Montpied, Clermont-Ferrand.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
English Abstract,
Clinical Trial, Phase II
|
